GlassScriptPhysician profile
Domenick J Roma
NPI 1023278967
$1,390.04
in general payments reported to CMS, 2019-2025
29 companies · $53.70 in 2025
The $53.70 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $925 · 2020: $154 · 2021: $64.78 · 2022: $17.30 · 2023: $136 · 2024: $39.11 · 2025: $53.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $228.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $165.80 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.88 | 2019-2020 | |
| Philips North America LLC | $124.56 | 2019-2021 | |
| Edwards Lifesciences Corporation | $115.85 | 2023 | Hemosphere |
| Genzyme Corporation | $79.64 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $75.57 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $57.40 | 2019-2025 | Zerbaxa |
| Astrazeneca Pharmaceuticals LP | $56.68 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $50.97 | 2019 | |
| Jazz Pharmaceuticals INC. | $49.81 | 2019 | |
| Allergan, INC. | $47.96 | 2019-2020 | |
| Tetraphase Pharmaceuticals, INC. | $45.63 | 2019 | |
| Haemonetics Corporation | $39.11 | 2024 | Teg6s Hemostasis System |
| Grifols USA, LLC | $38.26 | 2019 | |
| Genentech USA, INC. | $36.71 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $28.78 | 2019 | |
| Arbor Pharmaceuticals, INC. | $27.85 | 2019-2020 | |
| Mylan Specialty L.P. | $20.45 | 2019 | |
| Ceribell, INC. | $20.00 | 2023 | Ceribell Rapid Response Eeg |
| Stryker Corporation | $16.92 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shire North American Group INC | $16.52 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.17 | 2019 | |
| Biogen, INC. | $16.00 | 2021 | |
| Ge Healthcare | $15.35 | 2025 | |
| Portola Pharmaceuticals, LLC | $14.84 | 2019 | |
| Insmed, INC. | $14.68 | 2019 | |
| Apria Healthcare LLC | $14.18 | 2021 | |
| Mallinckrodt Enterprises LLC | $12.65 | 2019 | |
| Circassia INC. | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Domenick Roma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.